PMID- 17614110 OWN - NLM STAT- MEDLINE DCOM- 20071018 LR - 20131121 IS - 0041-008X (Print) IS - 0041-008X (Linking) VI - 223 IP - 3 DP - 2007 Sep 15 TI - Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation. PG - 195-205 AB - Previous work from our group indicated that alpha7 nicotinic acetylcholine receptors (alpha7 nAChR) potentially play a role in methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity. The aims of the present study were two-fold: (1) to demonstrate the interaction of METH and MDMA with homomeric alpha7 nAChR ([(3)H]methyllycaconitine binding) and other heteromeric subtypes ([(3)H]epibatidine binding); and (2) to show the effects of amphetamine derivative pretreatment on the density of binding sites. METH and MDMA displaced [(3)H]methyllycaconitine and [(3)H]epibatidine binding in membranes from NGF-differentiated PC 12 cells and mouse brain, with K(i) values in the micromolar range, MDMA revealing a greater affinity than METH. In addition, METH and MDMA induced a time- and concentration-dependent increase in [(3)H]methyllycaconitine and [(3)H]epibatidine binding; which had already been apparent after 6 h of pretreatment, and which peaked in differentiated PC 12 cells after 48 h. The highest increases were found in [(3)H]epibatidine binding, with MDMA inducing higher increases than METH. Treatment with METH and MDMA increased B(max) of high-affinity sites for both radioligands without affecting K(d). The heightened binding was inhibited by pretreatment with cycloheximide, suggesting the participation of newly synthesised proteins while inhibition of protein trafficking to plasma membrane did not block up-regulation. The effects of protein kinase and cyclophilin inhibitors on such up-regulation were explored, revealing a rapid, differential and complex regulation, similar to that described for nicotinic ligands. All of these results demonstrate that METH and MDMA have affinity for, and can interact with, nAChR, inducing their up-regulation, specially when higher doses are used. Such effects may have a role in METH- and MDMA-induced neurotoxicity, cholinergic neurotransmission, and in processes related to addiction and dependence. FAU - Garcia-Rates, Sara AU - Garcia-Rates S AD - Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Nucli Universitari de Pedralbes, Universitat de Barcelona, 08028 Barcelona, Spain. FAU - Camarasa, Jordi AU - Camarasa J FAU - Escubedo, Elena AU - Escubedo E FAU - Pubill, David AU - Pubill D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070526 PL - United States TA - Toxicol Appl Pharmacol JT - Toxicology and applied pharmacology JID - 0416575 RN - 0 (Chrna7 protein, mouse) RN - 0 (Chrna7 protein, rat) RN - 0 (Receptors, Nicotinic) RN - 0 (alpha7 Nicotinic Acetylcholine Receptor) RN - 44RAL3456C (Methamphetamine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Binding, Competitive MH - *Brain/cytology/drug effects/metabolism MH - Cell Membrane/*drug effects/metabolism MH - Dose-Response Relationship, Drug MH - Male MH - Methamphetamine/*pharmacology MH - Mice MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - PC12 Cells MH - Radioligand Assay MH - Rats MH - Receptors, Nicotinic/*biosynthesis MH - Time Factors MH - Up-Regulation MH - alpha7 Nicotinic Acetylcholine Receptor EDAT- 2007/07/07 09:00 MHDA- 2007/10/19 09:00 CRDT- 2007/07/07 09:00 PHST- 2007/02/17 00:00 [received] PHST- 2007/05/16 00:00 [revised] PHST- 2007/05/19 00:00 [accepted] PHST- 2007/07/07 09:00 [pubmed] PHST- 2007/10/19 09:00 [medline] PHST- 2007/07/07 09:00 [entrez] AID - S0041-008X(07)00245-1 [pii] AID - 10.1016/j.taap.2007.05.015 [doi] PST - ppublish SO - Toxicol Appl Pharmacol. 2007 Sep 15;223(3):195-205. doi: 10.1016/j.taap.2007.05.015. Epub 2007 May 26.